Cancer News and Research

Latest Cancer News and Research

Cancer drug may delay progression of bone and other myeloma-related organ damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

28 Oct 2019

3D-printed cell traps help researchers remove the hay to expose cancer cells

Finding a handful of cancer cells hiding among billions of blood cells in a patient sample can be like finding a needle in a haystack. In a new approach enabled by 3D-printed cell traps, researchers are removing the hay to expose the cancer cells.

28 Oct 2019

Drugs can be safely delivered to cancerous lymph nodes using sound waves

Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. Tohoku University researchers tested the treatment on mice with metastatic breast cancer and published their findings in the journal Scientific Reports.

28 Oct 2019

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Recently, a drug named Pixantrone (PIX) was developed, which is far less damaging to the heart than previous, less advanced compounds. PIX is now used to treat cancers including non-Hodgkin's lymphoma and leukaemia, but a detailed knowledge of the molecular processes it uses to destroy cancer cells has been lacking so far.

28 Oct 2019

Teen e-cigarette use epidemic blamed on flavoured cartridges

Researchers from University of Southern California have found that more and more teenagers are sticking to vaping e cigarettes if they are being offered choices of different candy and fruity flavours.

28 Oct 2019

Health algorithm biased against black individuals finds study

A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, “Dissecting racial bias in an algorithm used to manage the health of populations,” was published this week in the latest issue of the journal Science.

26 Oct 2019

New cellular immunotherapy for cancers

A new study published in the journal Nature Communications on 22 October 2019 reports a new approach to cancer treatment that increases the immune capability of T lymphocytes against malignant cancers. This allows the T cells to successfully infiltrate and destroy these tumors. Animal trials have been completed and the researchers are planning clinical trials in human beings next.

26 Oct 2019

Multimillion-dollar ERC grant for study of cell fate in cancer

Harvard Medical School researcher Peter Kharchenko and three collaborators have won a six-year multimillion-dollar grant from the European Research Council for their work toward mapping out cellular decision-making during early development in an effort to illuminate new pathways for the treatment of pediatric cancer.

25 Oct 2019

New way to detect and attack cancer cells using solar technology

Scientific breakthroughs don't always happen in labs. For Sophia and Richard Lunt, Michigan State University researchers, many of their breakthroughs happen during neighborhood walks.

25 Oct 2019

Alder bark may be great source of anti-aging and anti-disease natural antioxidants

An alder bark may become a great source of anti-aging and anti-disease natural antioxidants. That's the results discovered by the IKBFU's Institute of Living Systems researchers.

25 Oct 2019

Diet high in fiber and yogurt linked with reduced risk for lung cancer

A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers published in JAMA Oncology.

25 Oct 2019

New algorithm flags cancer patients in need of advance care planning conversations

Many cancer patients do not get the opportunity to discuss their wishes for treatment until their illness has progressed too far, when it may be too late to have those discussions with loved ones or physicians.

25 Oct 2019

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis.

25 Oct 2019

TU Dresden scientists receive 4.5 million euros for fundamental research

Rapid growth of tumor tissue and metastasis formation are major problems of cancers. Cancer cells use a higher amount of energy than normal body cells and therefore undergo a metabolic reprogramming.

25 Oct 2019

Study finds molecular key to formation of mature and fully functioning T cells

In a finding that could help lead to new therapies for immune diseases like multiple sclerosis and IBD, scientists report in the Journal of Experimental Medicine identifying a gene and family of proteins critical to the formation of mature and fully functioning T cells in the immune system.

25 Oct 2019

People with mental disorders die many years earlier than others

Based on register data from 7,4 million persons living in Denmark between 1995 and 2015, the new nationwide study from the National Centre for Register-based Research at Aarhus BSS, Aarhus University, is the most comprehensive study ever done on mortality in persons with mental disorders.

25 Oct 2019

New nanoenzyme may help increase anti-tumor immunity

Theoretically, our immune system could detect and kill cancer cells. Unfortunately, tumors are well armed to fight these attacks. Despite modern cancer treatments, metastases and relapses remain a major problem.

25 Oct 2019

Neuroscientists identify how people can have a 'crash in visual processing'

Georgetown neuroscientists say they have identified how people can have a "crash in visual processing" - a bottleneck of feedforward and feedback signals that can cause us not to be consciously aware of stimuli that our brain recognized.

25 Oct 2019

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Study finds heightened risk of adverse financial outcomes prior to Alzheimer's diagnosis

Prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes - a likely consequence of compromised decision making when managing money, in addition to exploitation and fraud by others.

25 Oct 2019